Earnings release
Page 1
Exhibit 99.1 Purple Innovation Reports First Quarter 2025 Results; Reaffirms 2025 Guidance Exceeded Q1 Adjusted EBITDA Target; Delivered Q1 Sales Consistent with Guidance GAAP Gross Margin of 39.4% in Q1; Adjusted Gross Margin Above 40% for Fourth Consecutive Quarter Lehi, Utah, May 6, 2025 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure™ Mattress,” today announced results for the first quarter ended March 31, 2025. “Our first quarter performance reflects continued progress against our strategic priorities to stabilize and strengthen the business, and position Purple for long-term success,” said Rob DeMartini, CEO of Purple Innovation. “Revenue was in line with expectations, led by positive showroom growth, while continued improvement in gross margin and cost control drove Adjusted EBITDA ahead of guidance.” DeMartini continued, “As we move forward, our focus is on unlocking growth through continued innovation, including the full rollout of our Rejuvenate 2.0 collection, promoting our unique Gel Grid differentiation, and further optimizing our operations. Though the current economic environment remains uncertain, including the evolving impact of tariffs, we believe the structural improvements we have achieved, and investments we have made across innovation and partnership expansion, position us to navigate near-term pressures and deliver sustained growth over time.” First Quarter 2025 Financial Results First quarter 2025 net revenue declined by 13.2% to $104.2 million, compared to $120.0 million in the first quarter of 2024, reflecting the impact of persistent macroeconomic challenges and reduced demand in our wholesale and ecommerce channels. Gross profit for the first quarter decreased slightly to $41.0 million, compared to $41.7 million in the prior-year period. GAAP gross margin improved to 39.4%, an increase of 460 basis points year-over- year. Adjusted gross margin, which excludes restructuring and related charges, expanded to 40.3%, an improvement of 550 basis points year-over-year, driven by ongoing strategic sourcing efforts, production efficiencies, and the successful integration of our consolidated manufacturing operations. Operating expenses for the first quarter were $55.5 million, down 14.4% from $64.9 million in the first quarter 2024. This improvement was primarily driven by headcount reductions from our restructuring efforts and the in-sourcing of certain functions in marketing and finance. Net loss attributable to Purple Innovation, Inc. for the first quarter was ($19.1) million, an improvement from $(50.2) million in the prior year. Adjusted EBITDA for the first quarter was $(4.7) million, a significant improvement compared to $(13.2) million last year, driven by ongoing improvements in gross margin and well-managed expenses. Balance Sheet As of March 31, 2025, the Company had cash and cash equivalents of $21.6 million compared to $29.0 million as of December 31, 2024. Inventories as of March 31, 2025 totaled $60.2 million, down 16.5% compared to March 31, 2024, and an increase of 5.8% compared to December 31, 2024.
Page 2
2025 Outlook The Company is reiterating its 2025 outlook for full year revenue to be in the range of $465 to $485 million and adjusted EBITDA in the range of flat to positive $10 million. This guidance incorporates expected revenue and EBITDA contributions from expanded wholesale distribution in the second half of the year, and anticipated impacts from recently announced tariffs. Given the ongoing uncertainty around timing and scope of the tariffs, the Company’s outlook remains subject to change. Mattress Firm Update Today, the Company announced a significant expansion of its commercial partnership with Mattress Firm, through an agreement with Somnigroup International, Inc. Under the terms of this multifaceted agreement, Purple will more than double its retail footprint in Mattress Firm stores nationwide through the second half of 2025, from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots. The agreement also expands the existing strategic supply relationship with Tempur Sherwood, LLC, a subsidiary of Tempur Sealy, which will have the exclusive right to assemble certain product lines that Purple sells to Mattress Firm. Purple will maintain production of its proprietary grid technology and retain all related intellectual property. These expanded partnerships are a clear endorsement of Purple’s product differentiation and brand strength, and enable further investment in driving innovation, brand visibility, and top-line growth. Term Loan Amendment Subsequent to quarter-end, Purple successfully borrowed an incremental $20 million through an amendment to its Term Loan. These funds will support the ramp-up of one-time rollout costs and inventory production associated with the new, expanded distribution agreement with Mattress Firm. The additional capital also provides a financial cushion to help navigate ongoing market uncertainty. Conference Call and Webcast Information Purple Innovation, Inc. will host a live conference call to discuss financial results today, May 6, 2025 at 4:30 p.m. Eastern Time. To access the call dial 800-715-9871 (domestic) or 646-307-1963 (international). The call is also being webcast and can be accessed on the investor relations section of the Company's website, investors.purple.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days. About Purple Purple, the leading premium mattress company with the #1 Gel Grid technology in the world, the GelFlex® Grid, thoughtfully engineers products that make restorative sleep effortless for every kind of sleeper. The result of over 30 years of innovation and in comfort technologies, Purple's GelFlex Grid is the most significant advancement in mattresses in decades and is proven to reduce aches and pains. It instantly adapts as you move, balances temperature, relieves pressure and offers support in all the right places. Purple products, including mattresses, pillows, cushions, frames, sheets, and more, can be found online at Purple.com, in 55 Purple stores and over 3,000 retailers nationwide. Sleep Better. Live Purple. 2
Page 3
Forward Looking Statements Certain statements made in this release that are not historical facts are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Statements based on historical data are not intended and should not be understood to indicate the Company’s expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These statements include, but are not limited to, statements regarding our innovation pipeline, the timing of new product collection launches, our ability to improve profitability and optimize our business, and the future expansion of and benefits to us from our commercial relationships with Somnigroup International, Inc. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in raw material prices and cost of labor; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; changes in consumer demand, including pullbacks in consumer spending; disruptions to our manufacturing processes; and the risk factors outlined in the “Risk Factors” section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 14, 2025, and in our other filings made with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Non-GAAP Financial Measures EBITDA, adjusted gross margin, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non- GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure. With respect to the Company’s Adjusted EBITDA outlook for the full year 2025, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results. Investor Contact: Stacy Turnof, Edelman Smithfield stacy.turnof@edelmansmithfield.com 917-362-2581 3
Page 4
PURPLE INNOVATION, INC. Condensed Consolidated Balance Sheets (unaudited - in thousands, except par value) March 31, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 21,627 $ 29,011 Accounts receivable, net 24,388 33,057 Inventories 60,177 56,863 Prepaid expenses 5,582 6,023 Other current assets 1,627 1,414 Total current assets 113,401 126,368 Property and equipment, net 90,433 93,874 Operating lease right-of-use assets 77,817 75,516 Intangible assets, net 8,215 8,890 Other long-term assets 3,906 3,197 Total assets $ 293,772 $ 307,845 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 32,356 $ 40,639 Accrued compensation 7,445 9,415 Customer prepayments 3,726 6,411 Accrued rebates and allowances 6,159 10,013 Accrued warranty liabilities – current portion 7,351 6,114 Operating lease obligations – current portion 15,904 15,661 Other current liabilities 10,672 12,750 Total current liabilities 83,613 101,003 Related party debt 72,737 55,394 Accrued warranty liabilities, net of current portion 24,367 26,091 Operating lease obligations, net of current portion 88,281 87,072 Warrant liabilities 21,414 16,067 Other long-term liabilities 2,030 2,009 Total liabilities 292,442 287,636 Commitments and contingencies (Note 13) Stockholders’ equity: Class A common stock; $0.0001 par value, 210,000 shares authorized; 107,955 issued and outstanding at March 31, 2025 and 107,545 issued and outstanding at December 31, 2024 11 11 Class B common stock; $0.0001 par value, 90,000 shares authorized; 165 issued and outstanding at March 31, 2025 and at December 31, 2024 — — Additional paid-in capital 594,332 594,053 Accumulated deficit (593,003) (573,866) Total stockholders’ equity attributable to Purple Innovation, Inc. 1,340 20,198 Noncontrolling interest (10) 11 Total stockholders’ equity 1,330 20,209 Total liabilities and stockholders’ equity $ 293,772 $ 307,845 4
Page 5
PURPLE INNOVATION, INC. Condensed Consolidated Statements of Income (unaudited - in thousands, except per share amounts) Three Months Ended March 31, 2025 2024 Revenues, net $ 104,171 $ 120,033 Cost of revenues: Cost of revenues 62,207 78,313 Cost of revenues - restructuring related charges 918 — Total cost of revenues 63,125 78,313 Gross profit 41,046 41,720 Operating expenses: Marketing and sales 36,626 41,462 General and administrative 14,487 19,728 Research and development 2,452 3,666 Restructuring, impairment and other related charges 1,960 — Total operating expenses 55,525 64,856 Operating loss (14,479) (23,136) Other income (expense): Interest expense (4,764) (4,474) Other income, net 69 4,394 Gain (loss) on extinguishment of debt — (3,394) Change in fair value – warrant liabilities 49 (23,599) Total other income (expense), net (4,646) (27,073) Net loss before income taxes (19,125) (50,209) Income tax expense (41) (59) Net loss (19,166) (50,268) Net loss attributable to noncontrolling interest (29) (51) Net loss attributable to Purple Innovation, Inc. $ (19,137) $ (50,217) Net loss per share: Basic $ (0.18) $ (0.47) Diluted $ (0.18) $ (0.47) Weighted average common shares outstanding: Basic 107,596 106,022 Diluted 107,596 106,022 5
Page 6
PURPLE INNOVATION, INC. Condensed Consolidated Statements of Cash Flows (unaudited - in thousands) Three Months Ended March 31, 2025 2024 Cash flows from operating activities: Net loss $ (19,166) $ (50,268) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 5,050 6,382 Non-cash interest 2,120 1,563 Paid-in-kind interest 2,789 1,850 Non-cash restructuring, impairment and other related charges 635 — Loss on extinguishment of debt — 3,394 Loss on disposal of property and equipment 88 112 Change in fair value – warrant liabilities (49) 23,599 Stock-based compensation 368 492 Changes in operating assets and liabilities: Accounts receivable 8,669 10,060 Inventories (3,314) (5,150) Prepaid expenses and other assets 2,229 66 Operating leases, net (848) (209) Accounts payable (9,701) (7,043) Accrued compensation (1,970) 4,724 Customer prepayments (2,685) (1,724) Accrued rebates and allowances (3,854) (4,717) Accrued warranty liabilities (487) 368 Other accrued liabilities (2,944) (313) Net cash used in operating activities (23,070) (16,814) Cash flows from investing activities: Sale of property and equipment 258 — Purchase of property and equipment (2,241) (3,038) Investment in intangible assets (161) (62) Net cash used in investing activities (2,144) (3,100) Cash flows from financing activities: Proceeds from related party loan 19,000 61,000 Payments on term loan — (25,000) Payments on revolving line of credit — (5,000) Payments for debt issuance costs (1,170) (3,466) Net cash provided by financing activities 17,830 27,534 Net increase (decrease) in cash, cash equivalents and restricted cash (7,384) 7,620 Cash and cash equivalents, beginning of the year 29,011 26,857 Cash and cash equivalents, end of the period $ 21,627 $ 34,477 6
Page 7
PURPLE INNOVATION, INC. RECONCILIATION OF GAAP TO NON-GAAP MEASURES (In thousands) Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted net loss, and adjusted net loss per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP. Reconciliation of GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA A reconciliation of GAAP net loss to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net loss before interest expense, income tax (benefit) expense, other income, net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to changes in the fair value of the warrant liability, stock-based compensation expense, restructuring related charges, nonrecurring legal fees, Board special committee costs, executive interim and search costs, severance costs and showroom opening and closing costs. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance. Three Months Ended March 31, 2025 2024 GAAP net loss $ (19,166) (50,268) Interest expense 4,764 4,474 Income tax expense 41 59 Other income, net (69) (4,394) Depreciation and amortization 5,050 6,382 EBITDA (9,380) (43,747) Adjustments: Change in fair value - warrant liability (49) 23,599 Loss on extinguishment of debt — 3,394 Stock-based compensation expense 406 492 Restructuring related charges 2,648 — Legal fees 233 837 Board special committee fees 174 — Executive interim and search costs — 1,448 Severance costs 1,209 780 Showroom opening/closing costs 33 1 Adjusted EBITDA $ (4,726) $ (13,196) 7
Page 8
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit A reconciliation of GAAP gross margin to the non-GAAP measures of adjusted gross margin is provided below. Adjusted gross profit represents net revenue less adjusted cost of revenue. Adjusted cost of revenues represents cost of revenues excluding restructuring charges recorded in cost of revenues. We believe adjusted gross profit provides additional useful information with respect to the impact of the restructuring and provides meaningful measures of our operating performance. (in thousands) Three Months Ended March 31, 2025 2024 Revenues, net $ 104,171 $ 120,033 Total cost of revenues 63,125 78,313 Restructuring charges in cost of revenues (918) — Adjusted cost of revenues 62,207 78,313 Adjusted gross profit $ 41,964 $ 41,720 Adjusted gross profit % 40.3% 34.8% Reconciliation of GAAP Net Loss to non-GAAP Adjusted Net Loss and Adjusted Net Loss per Diluted Share Our presentation of adjusted net loss assumes that all net loss is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net loss to noncontrolling interests), which assumes the full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net loss per share, diluted, is calculated by dividing adjusted net loss by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired Securities as of the beginning of each period presented. Adjusted net loss and adjusted net loss per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net loss and loss per share, as calculated in accordance with GAAP. We believe adjusted net loss and adjusted net loss per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net loss, the most directly comparable GAAP measure, to adjusted net loss and the computation of adjusted net loss per diluted share, are set forth below: Three Months Ended March 31, 2025 2024 Net loss $ (19,166) $ (50,268) Income tax (benefit) expense, as reported 41 59 Change in fair value – warrant liabilities (49) 23,599 Loss on extinguishment of debt — 3,394 Restructuring related charges 2,878 — Gain on insurance proceeds — (4,300) Board special committee fees 174 — Adjusted net loss before income taxes (16,122) (27,516) Adjusted income taxes(1) 4,176 7,127 Adjusted net loss $ (11,946) $ (20,389) Adjusted net income per share, diluted $ (0.11) $ (0.19) Adjusted weighted-average shares outstanding, diluted(2) 107,761 106,227 (1) Represents the estimated effective tax rate of 25.9% for the three months ended March 31, 2025 and 2024, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company’s blended state tax rates assuming no valuation allowance. (2) Assumes options and restricted stock units calculated in accordance with GAAP and the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period.
Page 9
8
Page 10
A reconciliation of net income (loss) per share, diluted, to adjusted net income per diluted share is set forth below for the three months ended March 31, 2025 and 2024: For the Three Months Ended March 31, 2025 March 31, 2024 Net Loss Weighted Average Shares, Diluted Net Loss per Share, Diluted Net Loss Weighted Average Shares, Diluted Net Loss per Share, Diluted Net loss attributable to Purple Innovation Inc.(1) $ (19,137) 107,596 (0.18) $ (50,217) 106,022 $ (0.47) Assumed exchange of shares(2) (29) 165 (51) 205 Net loss (19,166) (50,268) Adjustments to arrive at adjusted net loss before taxes(3) 3,044 22,752 Adjusted net loss before taxes (16,122) (27,516) Adjusted income tax benefit(4) 4,176 7,127 Adjusted net loss $ 11,946 107,761 (0.11) $ (20,389) 106,227 $ (0.19) (1) Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. (2) Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period and added in if not already included in the weighted average diluted shares. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. (3) Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. (4) Represents the estimated effective tax rate of 25.9% for the three months ended March 31, 2025 and 2024, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company’s blended state tax rates assuming no valuation allowance. 9